Devyser enters Strategic Supply Agreement with Illumina to offer sequencing instruments and products
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
News | September 15, 2019
Cancer is overtaking heart disease as the leading cause of death, according to a study published recently in The Lancet medical journal.
While heart disease remains the overall leading cause globally, the study of nearly 156k participants, across 21 countries over 11 years, has identified a trend that as living conditions improve, cancer begins to overtake heart disease. In middle-income countries cancer approaches the same rate, while in high-income countries it represents more than double the deaths of heart disease. These two diseases alone account for nearly 80% of deaths in middle-aged adults.
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA...
Read More
Devyser is proud to announce that the company has been awarded a tender by Oslo University Hospital...
Read More
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a new tender in...
Read More
Devyser is proud to announce that One Lambda Devyser Chimerism and Advyser Chimerism have been...
Read More